Literature DB >> 10678980

Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA.

C Elkins1, K J Morrow, B Olsen.   

Abstract

Haemophilus ducreyi is resistant to killing by normal serum antibody and complement. We discovered an H. ducreyi outer membrane protein required for expression of serum resistance and termed it DsrA (for "ducreyi serum resistance A"). The dsrA locus was cloned, sequenced, and mutagenized. An isogenic mutant (FX517) of parent strain 35000 was constructed and characterized, and it was found to no longer express dsrA. FX517 was at least 10-fold more serum susceptible than 35000. DsrA was expressed by all strains of H. ducreyi tested, except three naturally occurring, avirulent, serum-sensitive strains. FX517 and the three naturally occurring dsrA-nonexpressing strains were complemented in trans with a plasmid expressing dsrA. All four strains were converted to a serum-resistant phenotype, including two that contained truncated lipooligosaccharide (LOS). Therefore, serum resistance in H. ducreyi does not require expression of full-length LOS but does require expression of dsrA. The dsrA locus from eight additional H. ducreyi strains was sequenced, and the deduced amino acid sequences were more than 85% identical. The major difference between the DsrA proteins was due to the presence of one, two, or three copies of the heptameric amino acid repeat NTHNINK. These repeats account for the variability in apparent molecular mass of the monomeric form of DsrA (28 to 35 kDa) observed in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Since DsrA is present in virulent strains, is highly conserved, and is required for serum resistance, we speculate that it may be a virulence factor and a potential vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678980      PMCID: PMC97321          DOI: 10.1128/IAI.68.3.1608-1619.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibiotics.

Authors:  N Carbonetti; V Simnad; C Elkins; P F Sparling
Journal:  Mol Microbiol       Date:  1990-06       Impact factor: 3.501

Review 2.  Molecular aspects of some virulence factors of Haemophilus somnus.

Authors:  L B Corbeil
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

3.  Increased virulence of Yersinia pseudotuberculosis by two independent mutations.

Authors:  R Rosqvist; M Skurnik; H Wolf-Watz
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

Review 4.  Molecular basis for serum resistance in Neisseria gonorrhoeae.

Authors:  P A Rice
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  Phenotypic variation in epitope expression of the Neisseria gonorrhoeae lipooligosaccharide.

Authors:  M A Apicella; M Shero; G A Jarvis; J M Griffiss; R E Mandrell; H Schneider
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

6.  An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection.

Authors:  J A Al-Tawfiq; K R Fortney; B P Katz; A F Hood; C Elkins; S M Spinola
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

7.  Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.

Authors:  P J Hitchcock; T M Brown
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

8.  Analysis of the yopA gene encoding the Yop1 virulence determinants of Yersinia spp.

Authors:  M Skurnik; H Wolf-Watz
Journal:  Mol Microbiol       Date:  1989-04       Impact factor: 3.501

Review 9.  Biology of Haemophilus ducreyi.

Authors:  W L Albritton
Journal:  Microbiol Rev       Date:  1989-12

10.  Genital ulceration as a risk factor for human immunodeficiency virus infection.

Authors:  R M Greenblatt; S A Lukehart; F A Plummer; T C Quinn; C W Critchlow; R L Ashley; L J D'Costa; J O Ndinya-Achola; L Corey; A R Ronald
Journal:  AIDS       Date:  1988-02       Impact factor: 4.177

View more
  54 in total

1.  Transcription of candidate virulence genes of Haemophilus ducreyi during infection of human volunteers.

Authors:  R E Throm; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.

Authors:  Stanley M Spinola; Wei Li; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Barry P Katz; Robert S Munson
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

4.  Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.

Authors:  Robert A Fulcher; Leah E Cole; Diane M Janowicz; Kristen L Toffer; Kate R Fortney; Barry P Katz; Paul E Orndorff; Stanley M Spinola; Thomas H Kawula
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

6.  The LspB protein is involved in the secretion of the LspA1 and LspA2 proteins by Haemophilus ducreyi.

Authors:  Christine K Ward; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

7.  Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.

Authors:  G E Wood; S M Dutro; P A Totten
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.

Authors:  Malikah Abdullah; Igor Nepluev; Galyna Afonina; Sanjay Ram; Peter Rice; William Cade; Christopher Elkins
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

9.  Trimeric autotransporters require trimerization of the passenger domain for stability and adhesive activity.

Authors:  Shane E Cotter; Neeraj K Surana; Susan Grass; Joseph W St Geme
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

10.  Trimeric autotransporter DsrA is a major mediator of fibrinogen binding in Haemophilus ducreyi.

Authors:  William G Fusco; Christopher Elkins; Isabelle Leduc
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.